NCT02856165View on ClinicalTrials.gov

High-flow Nasal Oxygen Therapy in Hospitalized Infant With Moderate-to-severe Bronchiolitis

NACompletedINTERVENTIONAL
Enrollment

268

Participants

Timeline

Start Date

October 28, 2016

Primary Completion Date

November 15, 2017

Study Completion Date

November 23, 2017

Conditions
Bronchiolitis
Interventions
DEVICE

High-flow nasal canula oxygen therapy

High-flow nasal canula oxygen therapy (HNF) using Optiflow junior system and AIRVO2 turbine (F\&P, NZ) at initial flow to 3l/kg/min (up to a maximum of 20l/min), FiO2 adjusted for SpO2 \> 94%.

DEVICE

Low-flow oxygen therapy with standard nasal canula

flow adjusted to SpO2 \> 94% (up to a maximum of 2l/min).

Trial Locations (1)

94270

AP-HP, Bicêtre Hospital, Le Kremlin-Bicêtre

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02856165 - High-flow Nasal Oxygen Therapy in Hospitalized Infant With Moderate-to-severe Bronchiolitis | Biotech Hunter | Biotech Hunter